MVZ für Hämatologie und Onkologie Düsseldorf GmbH

What MVZ für Hämatologie und Onkologie Düsseldorf GmbH does

MVZ für Hämatologie und Onkologie Düsseldorf GmbH is a private German medical care center (Medizinisches Versorgungszentrum, structured as a GmbH) operating two outpatient clinics in Düsseldorf, Germany, under the corporate ownership of alanta med GmbH. The practice delivers guideline-based outpatient hematology and oncology care, organized as an integrated service portfolio spanning Onkologie (cancer treatment including chemotherapy), Hämatologie (blood disease diagnosis and therapy), Diagnostik (diagnostic services), Therapie (ambulatory treatment), and Nachsorge (follow-up care including rehabilitation counseling and vocational reintegration). Care is delivered by a small named clinical team led by Fachärzte Frank Fox (additionally certified in Palliativmedizin) and Dr. med. Margit Seidelmann, supported by nursing and administrative staff, with managing directors Bernd Rudloff and Dr. Guido Tuschen overseeing the corporate entity.

The practice positions itself as clinic-independent, selecting the most appropriate partner from an established network — including St. Martinus Krankenhaus, Sana Klinik Düsseldorf, Schön Klinik Düsseldorf, UniversitätsTumorZentrum UTZ at Uniklinik Düsseldorf, and Paracelsus Klinik Golzheim — for each individual patient case. This enables seamless hand-offs between ambulatory and inpatient care. The primary site at Grabenstraße 17 occupies the 4th floor of the Wilhelm-Marx-Haus (barrier-free, central, served by the Heinrich-Heine-Allee ÖPNV stop); a satellite Nebensbetriebsstätte operates on the 3rd floor of Paracelsus Klinik at Friedrich-Lau-Str. 11. The business operates entirely within the German statutory and private health insurance reimbursement framework (GKV/PKV), with no publicly disclosed pricing and no disclosed revenue figures; pricing is not publicly disclosed as the practice bills through regulated healthcare tariffs. Marketing is limited to a single practice website (onkologie-mvz-duesseldorf.de) and formal cancer-registry reporting is performed with Landeskrebsregister NRW. There is no app, no public API, no AI/ML capability, no disclosed funding, and no headcount growth data beyond a stated total of 5 employees.

Name

MVZ für Hämatologie und Onkologie Düsseldorf GmbH

Legal name

Medizinisches Versorgungszentrum für Hämatologie und Onkologie Düsseldorf GmbH

Website

https://onkologie-mvz-duesseldorf.de

Company type

Private

Operating status

Operating

Headcount range

1–10 employees

Short description

MVZ für Hämatologie und Onkologie Düsseldorf GmbH is a private Düsseldorf outpatient clinic providing guideline-based hematology and oncology care — diagnostics, therapy, and follow-up — to cancer and blood-disease patients, delivered by two specialist physicians across two locations within the alanta med GmbH network.

Ownership category

akta.pro rank

Product category

Outpatient Hematology and Oncology Care

NAICS

Offices of Physicians (62111), Ambulatory Health Care Services (621)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Specialty Outpatient Facilities, Nec (8093)

akta.pro industry

PRIMARYHLAKAFAB

Medical Oncology

Healthcare & Life Sciences/Specialist Medical Practice/Hematology & Oncology

SECONDARYHLAKAFAA

Medical Hematology (Benign Hematology)

Healthcare & Life Sciences/Specialist Medical Practice/Hematology & Oncology

Keywords

• Outpatient oncology care
• Hematology treatment
• Cancer diagnostics
• Medical care center
• Oncology follow-up

Headquarters

HQ city

Düsseldorf

HQ country

Germany

HQ region

Europe

Offices2 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Others

Distribution channels1 record

Marketing channels1 record

Core offering

MVZ für Hämatologie und Onkologie Düsseldorf GmbH is a medical care center (Medizinisches Versorgungszentrum) that delivers outpatient hematology and oncology services, including cancer treatment, blood disease diagnostics and therapy, and long-term follow-up care. The practice plans and supervises all ambulatory hematological and oncological therapies based on the latest medical findings and guidelines, tailored to individual patient needs, and integrates them with inpatient partners through its established medical network.

Product overview

MVZ für Hämatologie und Onkologie Düsseldorf GmbH operates as a single medical care center providing outpatient oncological and hematological services. The practice offers a unified service portfolio consisting of Oncology Services (Onkologie) for cancer treatment, Hematology Services (Hämatologie) for blood disorders, Diagnostics (Diagnostik), Therapy (Therapie), and Follow-up Care (Nachsorge). These services are delivered as an integrated care concept through a team of specialized physicians and nursing staff, supported by an interdisciplinary network of medical partners.

Differentiator

Problem solved

Functional benefit

Products and services

• Onkologie (Oncology Services) Individual treatment plans and holistic care for cancer patients, including chemotherapy and other oncological therapies delivered on an outpatient basis, planned and supervised by specialist physicians according to the latest medical guidelines.
• Hämatologie (Hematology Services) Outpatient diagnosis and treatment of hematological disorders (blood diseases), delivered by specialist physicians for internal medicine and hematology/internal oncology.
• Diagnostik (Diagnostics) Diagnostic services for oncological and hematological diseases, including laboratory diagnostics and other diagnostic procedures performed at the MVZ.
• Therapie (Therapy) Ambulatory oncological and hematological therapies based on the latest medical findings and guidelines, tailored to individual patient needs and delivered by the medical team.
• Nachsorge (Follow-up Care) Long-term follow-up care after completion of therapy, including ongoing monitoring, social-medical counseling, rehabilitation support, and vocational reintegration guidance for patients.

Segments3 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Six partnerships are on record, tiered minor and core.

• Landeskrebsregister NRW (LKR NRW)minorOthersLandeskrebsregister NRW (State Cancer Registry North Rhine-Westphalia) - partner for cancer registry data reporting and coordination.
• St. Martinus Krankenhaus DüsseldorfcoreStrategic or Co-development PartnerSt. Martinus Hospital - part of the medical network for seamless outpatient and inpatient care coordination.
• Sana Klinik DüsseldorfcoreStrategic or Co-development PartnerSana Hospital Düsseldorf - partner in the medical network for comprehensive patient care.
• Schön Klinik DüsseldorfcoreStrategic or Co-development PartnerSchön Klinik Düsseldorf - partner in the medical network for interdisciplinary care.
• Universitätstumorzentrum UTZ (Uniklinik Düsseldorf)coreStrategic or Co-development PartnerUniversity Tumor Center UTZ at University Hospital Düsseldorf - academic partner for tumor treatment and research.
• Paracelsus Klinik Golzheim DüsseldorfcoreStrategic or Co-development PartnerParacelsus Klinik at Golzheim - satellite location provider and partner in the medical network.

Recent moves5 records

Expansion highlights4 records

Regional players

• alanta med GmbH: Parent holding company and operator of a network of MVZs in Germany; directly comparable as the same operator with other hematology/oncology and specialty MVZ sites that share back-office, governance, and clinical model.

Broad incumbents

• OneOncology: U.S. partnership platform of independent community oncology practices; similar concept of independent specialist clinics affiliating under a shared operating umbrella with payers, pharma, and research ties.
• Schön Klinik Düsseldorf: Acute-care hospital in the same city with related oncology services; both cooperation partner and adjacent competitor for inpatient hematology/oncology referrals.
• Asklepios Klinik Düsseldorf: Major German private hospital group with Düsseldorf presence and oncology departments; broad-incumbent competitor for inpatient and outpatient hematology/oncology care in the same catchment area.
• Sana Klinikum Düsseldorf: Large German hospital group with Düsseldorf site offering oncology and internal medicine; both a partner in the MVZ's network and a broad-incumbent oncology provider in the same market.
• US Oncology Network (McKesson): Large U.S. network of community oncology practices under one management/operating umbrella; comparable operating concept (multi-site outpatient hematology/oncology clinics with shared services) and a structural reference point for the alanta med MVZ network model.
• Universitätsklinikum Düsseldorf – UniversitätsTumorZentrum (UTZ): Academic hospital-based oncology center operating in the same city and already a strategic partner; provides competing inpatient oncology, clinical trials, and specialty hematology that overlap with the MVZ's outpatient services.
• Helios Klinikum Düsseldorf / Helios Health: Germany's largest private hospital operator, with a Düsseldorf site providing oncology/hematology services across the value chain; competes broadly for the same patient pool and referral relationships.
• Medicover – Hematology & Oncology Centers: Pan-European private healthcare operator running multiple hematology/oncology outpatient clinics; comparable business model as a multi-site ambulatory cancer care provider, albeit at much larger scale.

Direct peers

• Onkologische Schwerpunktpraxis / Hämatologische Praxis (German specialist oncology MVZs): Generic category of German outpatient hematology/oncology specialist practices (Schwerpunktpraxen/MVZs) of similar scale and operating model across German cities; directly comparable in services, payer mix, and clinical scope.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/mvz-f%C3%BCr-h%C3%A4matologie-und-onkologie-d%C3%BCsseldorf-gmbh

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MVZ für Hämatologie und Onkologie Düsseldorf GmbH